在接受巴里西提尼布治疗的脱发区域患者中,牛皮的病程
Enrico Matteini1, Fabio Artosi1, Giacomo Caldarola2
1Dermatology Unit, Department of Systems Medicine, University of Rome "Tor Vergata", 00134 Rome, Italy.
Clinics and practice
|February 26, 2026
概括
巴里西替尼 (baricitinib) 有效地治疗严重的脱发症 (AA),并显示出对牛皮的潜在益处. 然而,它对牛皮关节炎 (PsA) 不是最佳的,这表明需要进一步研究管理多种免疫媒介疾病.
科学领域:
- 皮肤病学 皮肤病学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 大白发症 (AA) 和牛皮是免疫媒介疾病,具有共同的致病机制.
- 雅努斯激酶抑制剂 (JAKi) 已被批准用于AA,但它们在同时存在的牛皮和牛皮性关节炎 (PsA) 中的疗效尚不清楚.
研究的目的:
- 评估巴里西提尼布在患有严重AA和同时存在的牛皮和/或PSA的患者的疗效和安全性.
- 使用验证的评分系统评估治疗结果.
主要方法:
- 五名患有严重AA和并发牛皮/PsA的患者的回顾性病例系列.
- 巴里西提尼布4毫克/天,在4周,24周和52周进行评估.
- 使用的脱发症严重程度工具 (SALT),牛皮区域和严重程度指数 (PASI) 和患者视觉模拟量表 (pVAS) 成绩.
主要成果:
- 一名患者实现了完全的AA缓解;两名患者改善到SALT<20.
- 牛皮得分 (PASI) 保持稳定.
- 一名PsA患者出现恶化 (pVAS 9) 并停止治疗.
结论:
- 巴里西替尼 (baricitinib) 证明了对AA的有效性和对牛皮的潜在益处.
- 巴里西提尼布可能不是治疗PsA的最佳治疗方法.
- 需要进一步的研究来澄清巴里西提尼布在管理多种免疫媒介疾病中的作用.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
604
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
604
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
573
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
573
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
652
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
652
Inflammatory Bowel Disease IV: Pharmacological Management
852
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
852
Skin Diseases and Disorders
5.9K
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
5.9K
Inflammatory Bowel Disease II: Crohn's Disease
1.4K
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.4K


